Cost-Effectiveness and Cost-Benefit of Cervical Cancer Screening with Liquid Based Cytology Compared with Conventional Cytology in Germany
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference43 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance
3. Bruni LAG, Serrano B, Mena M, et al. Human Papillomavirus and related diseases in Germany. Summary report 10 December 2018. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre).
4. Robert Koch Institut. HPV-Prävalenzstudie 2017/18; 2018. Available from: https://www.rki.de/DE/Content/Infekt/Impfen/Forschungsprojekte/HPV-Praevalenzstudie/HPV_node.html. Accessed January 24, 2020. 2019.
5. Cost-effectiveness of primary HPV screening for cervical cancer in Germany – a decision analysis
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献